Inventor
KATTAR SOLOMON D
US17 patents
⚠️ This page may combine multiple inventors who share the name “KATTAR SOLOMON D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
10 patentsUS7834026B2Nov 16, 2010
Spirocyclic compounds
MERCK SHARP & DOHME17 citations91
US9353066B2May 31, 2016
Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors
MERCK SHARP & DOHME11 citations82
US9242984B2Jan 26, 2016
Pyrazolyl derivatives as Syk inhibitors
MERCK SHARP & DOHME12 citations82
US9416111B2Aug 16, 2016
Substituted diazine and triazine spleen tyrosine kinease (Syk) inhibitors
MERCK SHARP & DOHME4 citations72
US9969749B2May 15, 2018
Inhibitors of IRAK4 activity
MERCK SHARP & DOHME6 citations71
US9932350B2Apr 3, 2018
Inhibitors of IRAK4 activity
MERCK SHARP & DOHME5 citations71
US9926330B2Mar 27, 2018
Inhibitors of IRAK4 activity
MERCK SHARP & DOHME5 citations71
US9376418B2Jun 28, 2016
Substituted pyridine spleen tyrosine kinase (SYK) inhibitors
MERCK SHARP & DOHME5 citations71
US10508108B2Dec 17, 2019
Tricyclic compounds as inhibitors of mutant IDH enzymes
MERCK SHARP & DOHME1 citations59
US9670196B2Jun 6, 2017
Thiazole-substituted aminoheteroaryls as Spleen Tyrosine Kinase inhibitors
MERCK SHARP & DOHME0 citations40
MERCK SHARP & DOHME LLC
3 patentsUS12319671B2Jun 3, 2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC0 citations48
US12516039B2Jan 6, 2026
N-linked isoquinoline amides as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC0 citations47
US12540131B2Feb 3, 2026
N-(heteroaryl) quinazolin-2-amine derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC0 citations42